A cancer diagnosis is devastating for any pet owner, but families facing canine lymphoma now have another treatment option to discuss with their veterinarian. Dechra announced September 23 that ...

Canine lymphoma is the most commonly diagnosed cancer in dogs. This is why November 7th has been designated as National Canine Lymphoma Awareness Day. This day was created in 2015 by Terry Simmons, a ...

Addressing a longstanding need for additional canine lymphoma treatment options, Laverdia® helps veterinary care teams and pet owners begin care at home from Day 1 after diagnosis. BOSTON, Sept. 23, ...

When Cory Padilla felt swollen lymph nodes in the neck of his dog, Copper, he knew it was time to take his best friend to the vet. Padilla told The Daily Beast that Copper, a beagle and German ...

Back in 2018, nine pet dogs suffering from various types of cancer participated in the clinical trial of an immunotherapy treatment that was developed by engineering a livestock virus called vesicular ...

A case report describes a dog with chronic protein-losing enteropathy that developed a rare ovarian T-cell lymphoma, ...

Add Yahoo as a preferred source to see more of our stories on Google. On January 16, 2026, the U.S. Food and Drug Administration (FDA) released a statement saying they had granted full approval of a ...

The FDA has approved Laverdia, a drug to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system. Laverdia is an oral treatment and only available by prescription from a ...

BOSTON, Sept. 23, 2026 /PRNewswire/ -- Dechra, a global leader in veterinary specialty care, today announced the availability of Laverdia® (verdinexor tablets), the first and only FDA-approved oral ...